Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α
- 6 November 2007
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 430 (3) , 264-268
- https://doi.org/10.1016/j.neulet.2007.11.001
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Diabetes and Depression: A Review of the LiteratureNursing Clinics of North America, 2007
- Gestational Stress Leads to Depressive-Like Behavioural and Immunological Changes in the RatNeuroimmunomodulation, 2006
- The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokinesMolecular Psychiatry, 2006
- Impaired health‐related quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levelsJournal of Viral Hepatitis, 2006
- Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patientsJournal of Viral Hepatitis, 2006
- Cytokines sing the blues: inflammation and the pathogenesis of depressionTrends in Immunology, 2006
- Addressing Tri‐Morbidity (Hepatitis C, Psychiatric Disorders, and Substance Use): The Importance of Routine Mental Health Screening as a Component of a Comanagement Model of CareClinical Infectious Diseases, 2005
- Evidence-informed assessment and treatment of depression in HCV and interferon-treated patientsInternational Review of Psychiatry, 2005
- IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicityMolecular Psychiatry, 2004
- Association of interferon-α-induced depression and improved treatment response in patients with hepatitis CNeuroscience Letters, 2004